Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma
about
Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cellsEctopic expression of the serine protease inhibitor PI9 modulates death receptor-mediated apoptosisIntracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell deathLow concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cellsGranzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.Evidence for the importance of personalized molecular profiling in pancreatic cancer.A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.Death by a thousand cuts: granzyme pathways of programmed cell deathAcidic stress promotes a glioma stem cell phenotype.Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme InhibitorsInhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.Biomarkers for the development of cancer vaccines: current status.Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine modelA new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patientsHypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.Serpins in T cell immunity.An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis.Tumor evasion from T cell surveillance.Granzyme M: behind enemy lines.Serpins prevent granzyme-induced death in a species-specific manner.Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.
P2860
Q24293644-F518130A-568F-4016-BF19-9A28816CCE1CQ24304892-537DFFD5-E821-4A33-9B04-842BD328A556Q24324387-0107C27C-72B9-4518-9911-7B52256E287DQ24656281-5CF4AA00-C5AB-44D1-902F-54EC06600AEDQ30571557-6BF8F609-813A-4D09-82D3-F3074217B94BQ33367810-DB0984FB-5AFD-4615-BAA2-627306A91633Q34387784-876087A0-F9E4-4A43-B760-135409306C1FQ34438994-738253B5-9258-4698-A721-36D9444331D9Q34588821-38C09334-FF27-4155-B7B5-742FD44AFA26Q34985109-5D26A03C-9369-41C9-B0B0-8319A72A59CAQ35952443-0A8183C9-411C-46BA-AFA7-B41B3039FA85Q36106303-4CC360EC-E205-4B6E-A1C3-1E36A5BFB387Q36677261-69DF1DF3-A11A-4505-AC26-76F1981E8FFCQ36736543-96E32ABC-B0A5-4FF1-A808-2D85589E321EQ36741592-E80962AE-AD4F-45E9-86AA-A37339DB3AE6Q36823719-0D0D16A8-CCFD-4EC0-9281-B8536EB39440Q36849529-658C89CD-DB34-49AC-94CA-A329A8BAF3B4Q36889688-8865C805-A6C3-4300-BFDA-468B89EDCD55Q37221453-17A515D6-428F-49FE-8A81-7945FADA26F6Q37222018-9C11C0C1-9E19-4623-B2F2-0D26D17D719FQ37952002-F1D925CD-2CB8-4636-9737-304F736156A5Q37970674-6EFC297E-2F90-4999-B739-EC5FEDF3C622Q38177611-610D9F8F-7C1B-41BE-84FB-E5F80EFB060DQ40331824-6A2F7189-D429-4921-8AC6-4AA23DF9C2B8Q45201798-D81C74D4-EAA3-4DBD-8092-7F86989B870EQ50985152-7AE93AF8-1450-49D3-8167-1BDA382E184BQ52733768-459155B8-12CF-4F30-9594-552D4A7F8DA0
P2860
Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Expression of the apoptosis in ...... with stage III and IV melanoma
@ast
Expression of the apoptosis in ...... with stage III and IV melanoma
@en
Expression of the apoptosis in ...... with stage III and IV melanoma
@nl
type
label
Expression of the apoptosis in ...... with stage III and IV melanoma
@ast
Expression of the apoptosis in ...... with stage III and IV melanoma
@en
Expression of the apoptosis in ...... with stage III and IV melanoma
@nl
prefLabel
Expression of the apoptosis in ...... with stage III and IV melanoma
@ast
Expression of the apoptosis in ...... with stage III and IV melanoma
@en
Expression of the apoptosis in ...... with stage III and IV melanoma
@nl
P2093
P1476
Expression of the apoptosis in ...... with stage III and IV melanoma
@en
P2093
Alfonsus J M van den Eertwegh
Arnold Baars
Bellinda A Bladergroen
Chad M Gundy
Chris J L M Meijer
Donata Rimoldi
Inge S van Houdt
Jean A Kummer
Jettie J F Muris
Joost J Oudejans
P304
P356
10.1158/1078-0432.CCR-05-0306
P407
P577
2005-09-01T00:00:00Z